(60772-15) (Pancreas) 3b transverse view

Jan 10, 2005
Presentation Body
Latest in Industry News
Cancer Cell Target (1)
National Proton Conference highlights phase III trial data
April 10, 2026
Modernizing Radiotherapy Workflows
Sponsored
Modernizing Radiotherapy Workflows
March 17, 2026
Pet Brain Scan Adobe Michael dim5r Awl G7
FDA accepts Telix NDA for glioma PET agent Pixclara
April 10, 2026
Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.
Shine receives $263M conditional loan for Mo-99 isotope facility
April 9, 2026
Related Stories
Preloader Anim
Videos
AuntMinnieTV: What's an Aunt Minnie?
2004 12 30 14 06 23 706
Residents/Fellows
Ethnic South Asian radiologists absent from U.S. leadership roles
2004 12 13 13 20 07 706
Practice Management
Study delineates radiologist risk for malpractice claims
Modernizing Radiotherapy Workflows
Sponsor Content
Modernizing Radiotherapy Workflows
More in Industry News
National Proton Conference highlights phase III trial data
By AuntMinnie.com staff writers
Data supports survival benefit for intensity-modulated proton therapy (IMPT) in head and neck cancer.
April 10, 2026
Cancer Cell Target (1)
MRI accident investigation continues, lawsuit filed
By AuntMinnie.com staff writers
Next episode of "The Invisible Force" podcast coming soon.
April 10, 2026
Lawsuit Eccolo
FDA accepts Telix NDA for glioma PET agent Pixclara
By AuntMinnie.com staff writers
The NDA resubmission included additional data and statistical analysis requested by the U.S. FDA.
April 10, 2026
Pet Brain Scan Adobe Michael dim5r Awl G7
Shine receives $263M conditional loan for Mo-99 isotope facility
By AuntMinnie.com staff writers
Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.
April 9, 2026
Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.
Hyperfine wins CE Mark, UKCA approval for next-gen Swoop portable MRI
By AuntMinnie.com staff writers
Hyperfine has received CE Marking and UKCA approval for its Swoop portable brain MRI system and its Optive AI software.
April 9, 2026
Regulatory File Submit 400
GEHC, Medtronic link bkActiv ultrasound system to Stealth AXiS
By AuntMinnie.com staff writers
GE HealthCare and Medtronic will combine their respective ultrasound and surgical navigation systems for cranial procedures.
April 9, 2026
Ge Health Care Logo
Visage Imaging inks $14.4M contract with University of Maryland
By AuntMinnie.com staff writers
The contract covers Visage 7 Viewer and Visage 7 Workflow, to be deployed in the cloud across UMMS's network of academic, community, and specialty hospitals.
April 8, 2026
Visage
ABK Biomedical to build Y-90 microsphere facility
By AuntMinnie.com staff writers
Eye90 microspheres are an yttrium-90 (Y-90) radioembolization device in clinical development for liver cancer treatment.
April 8, 2026
Liver
Medline receives FDA warning letter over contrast syringes
By AuntMinnie.com staff writers
The company's contrast media syringes have been linked to air embolism risk.
April 8, 2026
Fda
First patients treated in RYZ401 radiopharmaceutical trial
By AuntMinnie.com staff writers
RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.
April 8, 2026
Atom Molecule
Public comfort with AI in health care falls, Ohio State survey finds
By AuntMinnie.com staff writers
Fewer Americans are open to AI being used in their healthcare, with comfort levels dropping significantly from 2024 to 2025.
April 7, 2026
Ai Hand
Siemens Healthineers, Radiopharm sign RAD101 supply agreement
By AuntMinnie.com staff writers
Siemens will manufacture and distribute doses of F-18–labeled RAD101 to support Radiopharm's Phase 3 U.S. registrational trial.
April 7, 2026
Siemens
Page 1 of 3611
Next Page